RemSleep Holdings, Inc. is a medical device manufacturer dedicated to forever changing the level of treatment provided to obstructive Sleep Apnea patients. Our focus is primarily designing and manufacturing devices and products for the treatment of Sleep Apnea and other respiratory conditions. With over 30 years of collective experience in CPAP therapy, the RemSleep team has extensive knowledge and understanding of CPAP and the challenges of patient compliance. We diligently strive for our products to make the difference and improve the condition of those suffering from Sleep Apnea.
Company profile
Ticker
RMSL
Exchange
Website
CEO
Tom Wood
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Bella Viaggio, Inc., Kat Gold Holdings Corp., OBICOM, INC.
SEC CIK
Corporate docs
IRS number
383759675
RMSL stock data
Latest filings (excl ownership)
10-Q
2024 Q2
Quarterly report
19 Aug 24
NT 10-Q
Notice of late quarterly filing
14 Aug 24
8-K
Other Events
10 Jul 24
10-Q
2024 Q1
Quarterly report
17 May 24
NT 10-Q
Notice of late quarterly filing
15 May 24
10-K
2023 FY
Annual report
16 Apr 24
NT 10-K
Notice of late annual filing
29 Mar 24
UPLOAD
Letter from SEC
29 Feb 24
424B3
Prospectus supplement
14 Feb 24
Financial summary
Quarter (USD) | Jun 24 | Mar 24 | Dec 23 | Sep 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 698.73 k | 698.73 k | 698.73 k | 698.73 k | 698.73 k | 698.73 k |
Cash burn (monthly) | 10.63 k | 31.96 k | 98.96 k | 156.56 k | 50.63 k | 50.78 k |
Cash used (since last report) | 30.78 k | 92.52 k | 286.44 k | 453.19 k | 146.57 k | 146.99 k |
Cash remaining | 667.95 k | 606.21 k | 412.28 k | 245.54 k | 552.16 k | 551.74 k |
Runway (months of cash) | 62.8 | 19.0 | 4.2 | 1.6 | 10.9 | 10.9 |
Institutional ownership, Q4 2023
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|
Press releases
REMSleep Patent Application Has Been Allowed by the United States Patent and Trademark Office
3 Sep 24
REMSleep Holdings Inc. Issues Shareholder Letter
6 Aug 24
REMSleep Holdings, Inc. Announces Distributor Request for DELTAWAVE Nasal Pillows System Samples
24 Jul 24
REMSleep Holdings Inc. Announces Strategic Marketing Plan for DELTAWAVE Nasal Pillows System
17 Jul 24
REMSleep Holdings Inc. Receives 510(K) Clearance on Product
9 Jul 24